101 related articles for article (PubMed ID: 2241194)
21. [CA 15.3, a marker of breast cancer].
Ruibal A
Med Clin (Barc); 1988 Sep; 91(9):341-3. PubMed ID: 3216756
[No Abstract] [Full Text] [Related]
22. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
23. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
Repetto L; Onetto M; Gardin G; Costanzi B; Giudici S; Vitiello E; Merlini L; Naso C; Zannini C; Paganuzzi M
Cancer Detect Prev; 1993; 17(3):411-5. PubMed ID: 8402728
[TBL] [Abstract][Full Text] [Related]
24. [Study on carbohydrate antigen NCC-ST-439 in breast cancer].
Suzuki S; Nihei M; Nomizu T; Watanabe T; Kimijima I; Tsuchiya A; Abe R
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):1019-26. PubMed ID: 2202768
[TBL] [Abstract][Full Text] [Related]
25. [Tumor markers in gastrointestinal cancer and its clinical significance].
Taguchi T; Ota J; Sumida S; Rii M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
[TBL] [Abstract][Full Text] [Related]
26. [CA 15-3 in the diagnosis and monitoring of carcinoma of the breast and its correlations with CEA].
Festa V; Alabiso O; Piantino P; Lisa F; Zanini M; Garrone C; Simone P; Morino M
Minerva Chir; 1989 Mar; 44(6):1015-20. PubMed ID: 2733831
[TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen, CA 19-9 and CA 50 in monitoring human squamous cell carcinoma of the esophagus.
Munck-Wikland E; Kuylenstierna R; Lindholm J; Wahren B
Anticancer Res; 1990; 10(3):703-8. PubMed ID: 2369087
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of present tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
[TBL] [Abstract][Full Text] [Related]
30. Periodic measurement of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels as postoperative surveillance after breast cancer surgery.
Nakamura T; Kimura T; Umehara Y; Suzuki K; Okamoto K; Okumura T; Morizumi S; Kawabata T
Surg Today; 2005; 35(1):19-21. PubMed ID: 15622458
[TBL] [Abstract][Full Text] [Related]
31. Tumour markers in gastric cancer.
Roberts PJ; Haglund C; Onali M; Kuusela P
Ann Chir Gynaecol; 1989; 78(1):38-40. PubMed ID: 2667447
[TBL] [Abstract][Full Text] [Related]
32. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
[TBL] [Abstract][Full Text] [Related]
33. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
[TBL] [Abstract][Full Text] [Related]
34. [Tumor markers in the upper intestinal tract--stomach and pancreas].
Pointner R; Conrad F; Schwab G
Wien Klin Wochenschr; 1989 Jul; 101(14):482-4. PubMed ID: 2773485
[TBL] [Abstract][Full Text] [Related]
35. Serological monitoring of advanced breast cancer treated by systemic cytotoxic using a combination of ESR, CEA, and CA 15.3: fact or fiction?
Dixon AR; Jönrup I; Jackson L; Chan SY; Badley RA; Blamey RW
Dis Markers; 1991; 9(3-4):167-74. PubMed ID: 1813208
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated antigen CA 15-3 in the diagnostics of breast tumours.
Eskelinen M; Tikanoja S; Valkamo E; Loikkanen M; Collan Y
Scand J Clin Lab Invest; 1988 Nov; 48(7):653-8. PubMed ID: 3201097
[TBL] [Abstract][Full Text] [Related]
37. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
Komuro K; Watanabe K; Ishida T; Sakurai M; Amano R; Hagiwara H; Hara Y; Hanzawa T; Itsubo K
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3145-9. PubMed ID: 3465273
[TBL] [Abstract][Full Text] [Related]
38. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
Paulick R; Caffier H; Paulick M
Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
[TBL] [Abstract][Full Text] [Related]
39. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
Wu JT
Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
[TBL] [Abstract][Full Text] [Related]
40. Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients.
Gion M; Peloso L; Mione R; Vignati G; Fortunato A; Saracchini S; Biasioli R; Gulisano M; Cappelli G
Cancer J; 2001; 7(3):181-90. PubMed ID: 11419026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
